This wiki has undergone a migration to Confluence found Here
Difference between revisions of "Policy Committee"
Jump to navigation
Jump to search
Hbuitendijk (talk | contribs) |
Hbuitendijk (talk | contribs) |
||
| Line 19: | Line 19: | ||
* Active | * Active | ||
| − | ** [[PAC: | + | ** [[PAC: ONC-CMS Interoperability RFI| Advancing Interoperability and Health Information Exchange]] |
** [[PAC: FDA UDI|FDA UDI]] | ** [[PAC: FDA UDI|FDA UDI]] | ||
** [[PAC: Blue Button|Blue Button]] | ** [[PAC: Blue Button|Blue Button]] | ||
| Line 28: | Line 28: | ||
* Closed | * Closed | ||
| + | ** [[PAC: MU 3 RFC|MU 3 RFC]] | ||
** [[PAC: FDA AAMI|FDA AAMI]] | ** [[PAC: FDA AAMI|FDA AAMI]] | ||
** [[PAC: Clinical Quality for Meaningful Use Stage 3|Clinical Quality for Meaningful Use Stage 3]] | ** [[PAC: Clinical Quality for Meaningful Use Stage 3|Clinical Quality for Meaningful Use Stage 3]] | ||
Revision as of 18:46, 3 April 2013
The HL7 Policy Advisory Committee (PAC) is a Board-appointed committee, evaluating HL7's role in the advocacy continuum. The PAC operates within the parameters identified in the Stance Document.
Contents
Work Group Meeting and Conference Call Agendas and Minutes
All agendas and minutes are posted to the HL7 Policy Committee Minutes page at http://www.hl7.org/Special/committees/policy/minutes.cfm
Current Activity
The Policy Advisory Committee is currently accepting input on those topics listed in the Active status to develop responses to various entities seeking input on proposed policy specific to health information technology and standards. Work Groups may post their responses to the wiki or submit comments to any member of the Policy Advisory Committee.
Backlog
- Pending
- Privacy & Security for Mobile Devices
- S&I Initiatives
- HIT-PC / HIT-SC testimonies
- PAC: HIPAA Privacy & Security Regulations
- PAC: Business Plan, PAC, and International Policies
- Meaningful Use Stage 3
- Secondary Use of Data - Canada (October, 2012)
- Active
- Closed
- MU 3 RFC
- FDA AAMI
- Clinical Quality for Meaningful Use Stage 3
- Medicare Physician Fee Schedule - Quality Reporting Initiatives
- FDA Request for Comments on Study Data Exchange Standards
- PAC: 2014 Edition Test Scripts
- AHRQ RFI on Quality Measurement
- Incorporation of Patient Generated Data for Meaningful Use Stage 3
- Interoperability Information of Digital Products and Services
- NwHIN Governance
- Federal Participation in Standards Development - Position Statement
- Meaningful Use Stage 2 - May 7, 2012
- Data Segmentation for Privacy Use Case Consensus Statement - Feb 3, 2012
- Meaningful Use Stage 1
- Policy News Room
Other Documents
- Workgroup Feedback on Stance Document
- See the Policy Advisory Committee Documents page at http://www.hl7.org/Special/committees/policy/docs.cfm for other documents and presentations.
